29 septiembre 2014
A world-first study heralds the efficacy of a targeted combination drug therapy after reporting major declines in the risk of disease progression and death in people with metastatic melanoma.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/oHYMDHfNuhU/140929105347.htm
